Inflammation and Regeneration

Aims & Scope

Inflammation and Regeneration is the official journal of the Japanese Society of Inflammation and Regeneration (JSIR).

This journal provides an open access forum which covers a wide range of scientific topics in the basic and clinical researches on inflammation and regenerative medicine.

It also covers investigations of infectious diseases, including COVID-19 and other emerging infectious diseases, which involve the inflammatory responses.

Inflammation research and regenerative medicine are tightly linked research areas in life sciences and their significance in translational research is rapidly increasing.

From this aspect, this journal encourages the submission of manuscripts whose scope bridges these fields of research.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology, Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• A large-scale survey of patients with relapsing polychondritis in Japan

  Citation: 32

  Authors: Hiroshi, Yoshihisa, Jun, Kazuo, Noboru

• Platelet lysate membranes as new autologous templates for tissue engineering applications

  Citation: 28

  Authors: =Pedro, V^|^iacute;tor E., Ana Rita C., Cl^|^aacute;udia, Marta H. G., Jo^|^atilde;o F., Rui L., Manuela E

• The emergence of amnion epithelial stem cells for the treatment of Multiple Sclerosis

  Citation: 23

  Authors: Courtney, Christopher, Claude

• IL-6 and lipid metabolism

  Citation: 22

  Authors: Misato, Masahiko

• Historical overview of psychoactive mushrooms

  Citation: 21

  Authors: Yoshihiro, Fumio, Tadahiro, Takahide

• Preparation of biodegradable iron oxide nanoparticles with gelatin for magnetic resonance imaging

  Citation: 20

  Authors: =Asahi, Jun-ichiro, Ichio, Yasuhiko

• Potential roles of microsomal prostaglandin E synthase-1 in rheumatoid arthritis

  Citation: 17

  Authors: Fumiaki, Rahul G., Shinichi, Fumitaka, Leslie J.

• Periodontal tissue regeneration by transplantation of adipose tissue-derived multi-lineage progenitor cells

  Citation: 15

  Authors: Masao, Keigo, Tomoaki, Satomi, Chiaki, Hanayuki, Akihumi, Hiroshi, Chun Man, Yoshiki, Masahiro, Tomoko, Masahide, Shinya

• Fingolimod (FTY720), the Sphingosine 1-Phosphate Receptor Modulator, as a New Therapeutic Drug in Multiple Sclerosis

  Citation: 14

  Authors: Kenji, Hirotoshi, Noriyasu, Yasuhiro, Kunio

• Interleukin-6; pathogenesis and treatment of autoimmune inflammatory diseases

  Citation: 13

  Authors: Toshio, Masashi, Kazuya, Tadamitsu